HomeTag#aaopt2022 - Verséa

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/10/rob-sambursky-zoom-interview.jpg?resize=600%2C400&ssl=1

Following the American Academy of Ophthalmology (AAO) 2022 Annual Meeting held in Chicago, Verséa Ophthalmics President, Rob Sambursky, MD, was interviewed by Ophthalmology Times to provide an overview of the company and its products. Dr. Sambursky spoke about BIOVANCE 3L Ocular, a 3-layered decellularized, dehydrated human amniotic membrane (DDhAM) designed for comfort and improved handleability,...

https://i0.wp.com/www.versea.com/wp-content/uploads/2022/10/sandiego-scaled.jpg?resize=1280%2C640&ssl=1

This week Verséa Ophthalmics team is presenting at the American Academy of Optometry AAOpt 2022 Meeting in San Diego (CA). Visit our booth # 405, where we will be demonstrating our new Tear-Based Point of Care (T-POC) Quantitative Testing Platform that consists of a portable, multifunctional reader and two tear-based quantitative biomarker test kits: –...